Related Experiment Video

Updated: Aug 20, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Can stem cells mend a broken heart?

Siamak Davani1, Frédéric Deschaseaux, David Chalmers

  • 1Laboratoire de Pharmacologie, EA 479, IFR 133, Faculté de Médecine, CHU Jean Minjoz, 25000 Besançon, France. siamak.davani@ufc.chu.univ-fcomte.fr

Cardiovascular Research
|January 11, 2005
PubMed

Insights

Stem cell therapy offers new hope for regenerating hearts damaged by myocardial infarction (MI). This review explores various stem cell types for cardiac cell therapy (CCT) to improve outcomes.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Myocardial infarction (MI) is a primary cause of heart failure globally.
  • Current treatments for MI are insufficient to replace necrotic cardiac myocytes and prevent left ventricular remodeling.
  • Stem cell plasticity presents novel therapeutic avenues for cardiac regeneration.

Purpose of the Study:

  • To review recent experimental data on stem cell sources for cardiac cell therapy (CCT).
  • To discuss the clinical potential of diverse stem cell types in regenerating the infarcted heart.
  • To highlight the need for optimizing stem cell selection for CCT.

Main Methods:

  • Literature review of experimental studies on stem cell therapy for cardiac regeneration.
  • Analysis of data concerning various stem cell types, including embryonic/foetal stem cells, myoblasts, and bone marrow stem cells.
  • Evaluation of the clinical applicability and potential of different stem cell sources for CCT.

Main Results:

  • A wide array of stem/progenitor cells have been investigated for CCT.
  • Experimental data show promise in using stem cells for cardiac repair.
  • The optimal choice of stem cells for effective CCT remains undetermined.

Conclusions:

  • Stem cell therapy holds significant potential for treating myocardial infarction and heart failure.
  • Further research is needed to optimize stem cell selection and application for CCT.
  • Advancements in stem cell plasticity offer new perspectives for cardiac regeneration strategies.

More Related Videos

Intramyocardial Cell Delivery: Observations in Murine Hearts08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...